Stocks · Health care · Biological Products, (No Diagnostic Substances)

Century Therapeutics, Inc.

IPSC Clue Score63
United States Fiscal year ends December CIK 0001850119 Results filed 12 Aug 2026

What the insiders did Net buying

By person

6 insiders · 23 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Chad Cowan
Chief Scientific Officer
$49.25K (1)
$2.74K (1)
+$46.52K
1,175,322
$1.79M
+458.5%
Gregory Russotti
See Remarks
—
$40.14K (7)
−$40.14K
601,971
$914.39K
+63.7%
Brent Pfeiffenberger
President and CEO
$47.68K (2)
$14.74K (1)
+$32.95K
3,633,839
$5.52M
+144.8%
Douglas Carr
SVP Finance & Operations
—
$28.81K (11)
−$28.81K
502,641
$763.51K
+58.5%
Adrienne Farid
Chief Operations Officer
—
—
—
250,141
$379.96K
+85.1%
Morgan Conn
Chief Finanical Officer
—
—
—
79,648
$120.99K
+32.4%

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 86,158,758 to 181,075,321 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.